• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NIB
Click for more information
0.00% 0.0¢

NORDIC INVESTMENT BANK - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
NIB Financial Report 201820/02/19
NIB Financial Report 201713/03/18
NIB Suspension and final removal of expired class from quotationPRICE SENSITIVE26/02/18
NIB NIBHG - Suspension and final removal of expired classPRICE SENSITIVE31/07/17
NIB Pricing Supp - 5.00% Medium Term Notes due 19 April 202224/05/17
NIB Appendix 3B - 5.00% Medium Term Notes due 19 April 202224/05/17
NIB Financial Report 201510/03/16
NIB NIBHD and HE - Suspension and removal of expired class25/03/15
NIB Financial Report 201411/03/15
NIB Pricing Supp - 2.70% medium term notes due 4 February 202010/03/15
NIB Appendix 3B - 2.70% medium term notes due 4 February 202010/03/15
NIB Pricing Supp - 2.70% Medium Term Notes due 4 February 202004/02/15
NIB Appendix 3B - 2.70% Medium Term Notes due 4 February 202004/02/15
NIB Pricing Supplement - 4.75% MTNs due 28 February 202418/09/14
NIB Appendix 3B - 4.75% MTNs due 28 February 202418/09/14
NIB NIBHC - Suspension and Removal of Expired ClassPRICE SENSITIVE13/08/14
NIB NIBHI - Pricing Supplement 4.75% MTNs due 28 February 202411/06/14
NIB NIBHI - Appendix 3B 4.75% MTNs due 28 February 202411/06/14
NIBAppendix 3B - 4.75% MTNs due 28 February 202409/05/14
NIBPricing Supplement - 4.75% MTNs due 28 February 202409/05/14
NIBAppendix 3B - 4.75% MTN due 28 February 202408/04/14
NIBPricing Supplement - 4.75% MTN due 28 February 202408/04/14
NIBAppendix 3B 4.75% MTNs due 28 February 202414/03/14
NIBPricing Supplement 4.75% MTNs due 28 February 202414/03/14
NIBFinancial Report 201312/03/14
NIBPricing Supplement - 3.50% MTNs due 28 February 201812/02/14
NIBAppendix 3B - 3.50% MTNs due 28 February 201812/02/14
NIBPricing Supplement 4.75% MTNs due 28 February 202431/01/14
NIBAppendix 3B 4.75% MTNs due 28 February 202431/01/14
NIBPricing Supplement - 4.75% MTNs due 28 February 202411/12/13
NIBAppendix 3B - 4.75% MTNs due 28 February 202411/12/13
NIBNIBHI - Pricing Supp 4.75% MTNs due 28 Febarury 202427/11/13
NIBNIBHI - Appendix 3B 4.75% MTNs due 28 Febarury 202427/11/13
NIBAUD/NZD MTN Program, updated Information Memorandum11/10/13
NIBPricing Supp - 4.75% Medium Tern Notes due 28 February 202430/08/13
NIBAppendix 3B - 4.75% Medium Tern Notes due 28 February 202430/08/13
NIBNIBHF - Pricing Supplement 5.00% MTNs due 19 April 202223/05/13
NIBNIBHF - Appendix 3B 5.00% MTNs due 19 April 202223/05/13
NIBNIB Financial Report 201213/03/13
NIBNIB - Pricing Supplement 3.50% MTNs due 28 February 201801/03/13
NIBNIB - Appendix 3B 3.50% MTNs due 28 February 201801/03/13
NIBNIB - Pricing Supplement 5.00% MTN due 19 April 202221/01/13
NIBNIB - Pricing Supplement 5.00% MTN due 19 April 202221/01/13
NIBNIB - Appendix 3B 5.00% MTN due 19 April 202221/01/13
NIBNIBHF - Pricing Supp Fixed Rate Notes due 19 April 202225/10/12
NIBNIBHF - Appendix 3B Fixed Rate Notes due 19 April 202225/10/12
NIBNIB - Pricing Supplement 3.50% MTN due 8 August 201714/08/12
NIBNIB - Appendix 3B 3.50% MTN due 8 August 201714/08/12
NIBNIB - Pricing Supplement 5.00% MTNs due 19 April 202228/06/12
NIBNIB - Appendix 3B 5.00% MTNs due 19 April 202228/06/12
NIBPricing Supplement 5.00% MTNs due 19 April 202219/04/12
NIBAppendix 3B 5.00% MTNs due 19 April 202219/04/12
NIBFinancial Report 201120/03/12
NIBMAP Cancellation:Not NIB s/holder 23/02/12 s/b NHF28/02/12
NIB +Change in substantial holding from PPT23/02/12
NIBFinancial Report 201016/03/11
NIBNIBHA - Final removal of expired class from quotation20/01/11
NIBNIBHA - Suspension from Official QuotationPRICE SENSITIVE12/01/11
NIBAppendix 3B 6.00% MTN due 6 April 201505/11/10
NIBPricing Supplement 6.00% MTN due 6 April 201505/11/10
NIBPricing Supplement Floating Rate MTN due 6 April 201506/04/10
NIBPricing Supplement 6.00% MTN due 6 April 201506/04/10
NIBAppendix 3B 6.00% Medium Term Notes due 6 April 201506/04/10
NIBAppendix 3B Floating Rate MTN due 6 April 201506/04/10
NIBAnnual Report 200912/03/10
NIBPricing Supplement 6.00% MTN due 20 August 201424/11/09
NIBAppendix 3B 6.00% MTN due 20 August 201424/11/09
NIBPricing Supplement 6.00% MTN due 20 August 201420/08/09
NIBAppendix 3B 6.00% MTN due 20 August 201420/08/09
NIBNordic Investment Bank Financial Report 200802/04/09
NIB Financial Report 2018
20/02/19
NIB Financial Report 2017
13/03/18
NIB Suspension and final removal of expired class from quotation
26/02/18PRICE SENSITIVE
NIB NIBHG - Suspension and final removal of expired class
31/07/17PRICE SENSITIVE
NIB Pricing Supp - 5.00% Medium Term Notes due 19 April 2022
24/05/17
NIB Appendix 3B - 5.00% Medium Term Notes due 19 April 2022
24/05/17
NIB Financial Report 2015
10/03/16
NIB NIBHD and HE - Suspension and removal of expired class
25/03/15
NIB Financial Report 2014
11/03/15
NIB Pricing Supp - 2.70% medium term notes due 4 February 2020
10/03/15
NIB Appendix 3B - 2.70% medium term notes due 4 February 2020
10/03/15
NIB Pricing Supp - 2.70% Medium Term Notes due 4 February 2020
04/02/15
NIB Appendix 3B - 2.70% Medium Term Notes due 4 February 2020
04/02/15
NIB Pricing Supplement - 4.75% MTNs due 28 February 2024
18/09/14
NIB Appendix 3B - 4.75% MTNs due 28 February 2024
18/09/14
NIB NIBHC - Suspension and Removal of Expired Class
13/08/14PRICE SENSITIVE
NIB NIBHI - Pricing Supplement 4.75% MTNs due 28 February 2024
11/06/14
NIB NIBHI - Appendix 3B 4.75% MTNs due 28 February 2024
11/06/14
NIBAppendix 3B - 4.75% MTNs due 28 February 2024
09/05/14
NIBPricing Supplement - 4.75% MTNs due 28 February 2024
09/05/14
NIBAppendix 3B - 4.75% MTN due 28 February 2024
08/04/14
NIBPricing Supplement - 4.75% MTN due 28 February 2024
08/04/14
NIBAppendix 3B 4.75% MTNs due 28 February 2024
14/03/14
NIBPricing Supplement 4.75% MTNs due 28 February 2024
14/03/14
NIBFinancial Report 2013
12/03/14
NIBPricing Supplement - 3.50% MTNs due 28 February 2018
12/02/14
NIBAppendix 3B - 3.50% MTNs due 28 February 2018
12/02/14
NIBPricing Supplement 4.75% MTNs due 28 February 2024
31/01/14
NIBAppendix 3B 4.75% MTNs due 28 February 2024
31/01/14
NIBPricing Supplement - 4.75% MTNs due 28 February 2024
11/12/13
NIBAppendix 3B - 4.75% MTNs due 28 February 2024
11/12/13
NIBNIBHI - Pricing Supp 4.75% MTNs due 28 Febarury 2024
27/11/13
NIBNIBHI - Appendix 3B 4.75% MTNs due 28 Febarury 2024
27/11/13
NIBAUD/NZD MTN Program, updated Information Memorandum
11/10/13
NIBPricing Supp - 4.75% Medium Tern Notes due 28 February 2024
30/08/13
NIBAppendix 3B - 4.75% Medium Tern Notes due 28 February 2024
30/08/13
NIBNIBHF - Pricing Supplement 5.00% MTNs due 19 April 2022
23/05/13
NIBNIBHF - Appendix 3B 5.00% MTNs due 19 April 2022
23/05/13
NIBNIB Financial Report 2012
13/03/13
NIBNIB - Pricing Supplement 3.50% MTNs due 28 February 2018
01/03/13
NIBNIB - Appendix 3B 3.50% MTNs due 28 February 2018
01/03/13
NIBNIB - Pricing Supplement 5.00% MTN due 19 April 2022
21/01/13
NIBNIB - Pricing Supplement 5.00% MTN due 19 April 2022
21/01/13
NIBNIB - Appendix 3B 5.00% MTN due 19 April 2022
21/01/13
NIBNIBHF - Pricing Supp Fixed Rate Notes due 19 April 2022
25/10/12
NIBNIBHF - Appendix 3B Fixed Rate Notes due 19 April 2022
25/10/12
NIBNIB - Pricing Supplement 3.50% MTN due 8 August 2017
14/08/12
NIBNIB - Appendix 3B 3.50% MTN due 8 August 2017
14/08/12
NIBNIB - Pricing Supplement 5.00% MTNs due 19 April 2022
28/06/12
NIBNIB - Appendix 3B 5.00% MTNs due 19 April 2022
28/06/12
NIBPricing Supplement 5.00% MTNs due 19 April 2022
19/04/12
NIBAppendix 3B 5.00% MTNs due 19 April 2022
19/04/12
NIBFinancial Report 2011
20/03/12
NIBMAP Cancellation:Not NIB s/holder 23/02/12 s/b NHF
28/02/12
NIB +Change in substantial holding from PPT
23/02/12
NIBFinancial Report 2010
16/03/11
NIBNIBHA - Final removal of expired class from quotation
20/01/11
NIBNIBHA - Suspension from Official Quotation
12/01/11PRICE SENSITIVE
NIBAppendix 3B 6.00% MTN due 6 April 2015
05/11/10
NIBPricing Supplement 6.00% MTN due 6 April 2015
05/11/10
NIBPricing Supplement Floating Rate MTN due 6 April 2015
06/04/10
NIBPricing Supplement 6.00% MTN due 6 April 2015
06/04/10
NIBAppendix 3B 6.00% Medium Term Notes due 6 April 2015
06/04/10
NIBAppendix 3B Floating Rate MTN due 6 April 2015
06/04/10
NIBAnnual Report 2009
12/03/10
NIBPricing Supplement 6.00% MTN due 20 August 2014
24/11/09
NIBAppendix 3B 6.00% MTN due 20 August 2014
24/11/09
NIBPricing Supplement 6.00% MTN due 20 August 2014
20/08/09
NIBAppendix 3B 6.00% MTN due 20 August 2014
20/08/09
NIBNordic Investment Bank Financial Report 2008
02/04/09
refresh Created with Sketch. REFRESH
 

Top Stories

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
HotCopper Highlights: Your most watched stocks for Week 46, 2024 What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play Empire Energy (ASX:EEG) has confirmed the NT government has delivered environmental approvals for Carpentaria.
Cyclone signs MOU with Vale for development of Iron Bear play Cyclone Metals Lt has signed a Memorandum of Understanding with Vale S.A to support development of the former's iron ore project in Canada
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.